Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy. [electronic resource]
Producer: 20040702Description: 90-6 p. digitalISSN:- 1083-7159
- Adult
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Drug Administration Schedule
- Epoetin Alfa
- Erythropoietin -- administration & dosage
- Female
- Hematinics -- administration & dosage
- Hemoglobins -- drug effects
- Humans
- Male
- Middle Aged
- Neoplasms -- complications
- Pilot Projects
- Practice Guidelines as Topic
- Recombinant Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.